| 000 | 01671 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513122805.0 | ||
| 264 | 0 | _c19970908 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0832-610X | ||
| 024 | 7 |
_a10.1007/BF03013388 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFleyfel, M | |
| 245 | 0 | 0 |
_aRecombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancy. _h[electronic resource] |
| 260 |
_bCanadian journal of anaesthesia = Journal canadien d'anesthesie _cJul 1997 |
||
| 300 |
_a735-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAcenocoumarol _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Valve Prosthesis _xadverse effects |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMitral Valve |
| 650 | 0 | 4 |
_aMitral Valve Insufficiency _xetiology |
| 650 | 0 | 4 |
_aPlasminogen Activators _xtherapeutic use |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Cardiovascular _xdrug therapy |
| 650 | 0 | 4 | _aPregnancy Outcome |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 700 | 1 | _aBourzoufi, K | |
| 700 | 1 | _aHuin, G | |
| 700 | 1 | _aSubtil, D | |
| 700 | 1 | _aPuech, F | |
| 773 | 0 |
_tCanadian journal of anaesthesia = Journal canadien d'anesthesie _gvol. 44 _gno. 7 _gp. 735-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF03013388 _zAvailable from publisher's website |
| 999 |
_c9212494 _d9212494 |
||